Good to Know > Sunicine: The best treatment for Kidney cancer
Sunicine: The best treatment for Kidney cancer
Sunitinib is used to treat certain types of cancers.
Arechar Healthcare introduces the launch of Sunicine. Sunitinib medicine is standard care for the treatment of kidney and liver cancer and it helps to stop and slow down the growth of cancerous cells. It includes all receptors for a platelet-derived growth factor (PDGF-Rs) and vascular endothelial growth factor receptors (VEGFRs), which play a role in both tumor angiogenesis and tumor cell proliferation and help to shrink the tumor. The manufacturing unit of Arechar Healthcare has provided key features of Sunicine.
Sunitinib is also used in the treatment of GIST (gastrointestinal stromal tumor; a type of tumor that grows in the stomach), or esophagus (the tube that connects the throat with the stomach).
Sunitinib is an indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. It blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation.
The molecular formula of sunitinib is C22H27FN4O2 and the weight of the molecule is 398.5 g/mol.
Sunicine is available in the strength of 50mg each tablet contains sunitinib as an active ingredient and it can be orally administered as prescribed by your doctor.
“After witnessing the radical shift in the healthcare industry, I decided that now is the right time to develop a new range of life-saving medicines to drive better outcomes for cancer patients,” said Mr.Harpreet Singh, Founder of Arechar Healthcare. “A commitment to the community in providing the highest quality pharmaceuticals product.”
“We are dedicated to caring for cancer patients, a simple and effective question team of Arechar Healthcare asked every cancer patient, ‘What can we do to help?’ Our mission is to put the cancer patient first and help them to reach the potential result,” said Mrs. Ruchika Rajbans, co-founder of Arechar Healthcare.
About Arechar Healthcare
Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.
Related hot topics
Bortecine, an effective drug for Blood cancer
Bortecine, for Multiple Myeloma and Mantle Cell Lymphoma
Arechar Healthcare provides independent and precise information about prescription drugs with the related news and press releases. This content is displayed for informational purposes only and is not intended to be an alternative for any medical advice/prescription or treatment. Do not delay or ignore any medical treatment owing to something you’ve read or seen on this website. Also, this website offers links to other websites, enabling the viewers to directly switch to that website for detailed information or accurate references. Thus, Arechar is not responsible for the content displayed on the linked websites or the content of the links in the linked website.